Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Patients with Abdominal Aortic Aneurysms: Nation-Wide Cohort Study

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 35, Issue 3, 2015, Pages 733-740

  Kristensen, Karl Emil ^a   Torp Pedersen, Christian ^b   Gislason, Gunnar Hilmar ^a,c   Egfjord, Martin ^d   Rasmussen, Henrik Berg ^e   Hansen, Peter Riis ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b AALBORG UNIVERSITY   (Denmark)

^c UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^d University of Copenhagen   (Denmark)

^e Mental Health Center Glostrup   (Denmark)

Author keywords

aneurysm; cardiovascular diseases; hypertension; pharmacoepidemiology; renin angiotensin system

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST;

ABDOMINAL AORTA ANEURYSM; ADULT; ANEURYSM SURGERY; ARTICLE; CARDIOVASCULAR MORTALITY; CAUSE OF DEATH; COHORT ANALYSIS; CONGESTIVE HEART FAILURE; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; AGED; AORTIC ANEURYSM, ABDOMINAL; CHI SQUARE DISTRIBUTION; COMPARATIVE STUDY; DENMARK; DRUG EFFECTS; EPIDEMIOLOGY; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; PROPORTIONAL HAZARDS MODEL; REGISTER; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TIME FACTOR; TREATMENT OUTCOME; VASCULAR SURGERY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; AORTIC ANEURYSM, ABDOMINAL; CHI-SQUARE DISTRIBUTION; DENMARK; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RENIN-ANGIOTENSIN SYSTEM; TIME FACTORS; TREATMENT OUTCOME; VASCULAR SURGICAL PROCEDURES;

EID: 84922254766     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.114.304428     Document Type: Article

References (29)

1. Baxter BT, Terrin MC, Dalman RL, Medical management of small abdominal aortic aneurysms. Circulation 2008 117 1883 1889. doi: 10.1161/CIRCULATIONAHA.107.735274
2. Svensjö S, Björck M, Gürtelschmid M, Djavani Gidlund K, Hellberg A, Wanhainen A, Low prevalence of abdominal aortic aneurysm among 65-year-old Swedish men indicates a change in the epidemiology of the disease. Circulation 2011 124 1118 1123. doi: 10.1161/CIRCULATIONAHA.111.030379
3. Conway AM, Malkawi AH, Hinchliffe RJ, Holt PJ, Murray S, Thompson MM, Loftus IM, First-year results of a national abdominal aortic aneurysm screening programme in a single centre. Br J Surg 2012 99 73 77. doi: 10.1002/bjs.7685
4. Davis M, Harris M, Earnshaw JJ, Implementation of the National Health Service Abdominal Aortic Aneurysm Screening Program in England. J Vasc Surg 2013 57 1440 1445. doi: 10.1016/j.jvs.2012.10.114
5. Svensjö S, Björck M, Wanhainen A, Current prevalence of abdominal aortic aneurysm in 70-year-old women. Br J Surg 2013 100 367 372. doi: 10.1002/bjs.8984
6. Go AS, Mozaffarian D, Roger VL, American Heart Association Statistics Committee and Stroke Statistics Subcommittee Heart disease and stroke statistics-2013 update: a report from the American Heart Association. Circulation 2013 127 e6 e245. doi: 10.1161/CIR.0b013e31828124ad
7. Rooke TW, Hirsch AT, Misra S, 2011 ACCF/AHA Focused Update of the Guideline for the Management of patients with peripheral artery disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 2011 124 2020 2045
8. Mentz RJ, Bakris GL, Waeber B, McMurray JJ, Gheorghiade M, Ruilope LM, Maggioni AP, Swedberg K, Pina IL, Fiuzat M, O'Connor CM, Zannad F, Pitt B, The past, present and future of renin-angiotensin aldosterone system inhibition. Int J Cardiol 2012 167 1677 1687
9. Ma TK, Kam KK, Yan BP, Lam YY, Renin-angiotensin-aldosterone system blockade for cardiovascular diseases: current status. Br J Pharmacol 2010 160 1273 1292. doi: 10.1111/j.1476-5381.2010.00750.x
10. Lu H, Rateri DL, Bruemmer D, Cassis LA, Daugherty A, Involvement of the renin-angiotensin system in abdominal and thoracic aortic aneurysms. Clin Sci (Lond) 2012 123 531 543. doi: 10.1042/CS20120097
11. Hackam DG, Thiruchelvam D, Redelmeier DA, Angiotensin-converting enzyme inhibitors and aortic rupture: a population-based case-control study. Lancet 2006 368 659 665. doi: 10.1016/S0140-6736(06)69250-7
12. Thompson A, Cooper JA, Fabricius M, Humphries SE, Ashton HA, Hafez H, An analysis of drug modulation of abdominal aortic aneurysm growth through 25 years of surveillance. J Vasc Surg 2010 52 55 61.e2. doi: 10.1016/j.jvs.2010.02.012
13. Sweeting MJ, Thompson SG, Brown LC, Greenhalgh RM, Powell JT, Use of angiotensin converting enzyme inhibitors is associated with increased growth rate of abdominal aortic aneurysms. J Vasc Surg 2010 52 1 4. doi: 10.1016/j.jvs.2010.02.264
14. Bruemmer D, Daugherty A, Lu H, Rateri DL, Relevance of angiotensin II-induced aortic pathologies in mice to human aortic aneurysms. Ann N Y Acad Sci 2011 1245 7 10. doi: 10.1111/j.1749-6632.2011.06332.x
15. Nagashima H, Uto K, Sakomura Y, Aoka Y, Sakuta A, Aomi S, Hagiwara N, Kawana M, Kasanuki H, An angiotensin-converting enzyme inhibitor, not an angiotensin II type-1 receptor blocker, prevents beta-aminopropionitrile monofumarate-induced aortic dissection in rats. J Vasc Surg 2002 36 818 823
16. Davis FM, Rateri DL, Daugherty A, Mechanisms of aortic aneurysm formation: translating preclinical studies into clinical therapies. Heart 2014 100 1498 1505. doi: 10.1136/heartjnl-2014-305648
17. Malekzadeh S, Fraga-Silva RA, Trachet B, Montecucco F, Mach F, Stergiopulos N, Role of the renin-angiotensin system on abdominal aortic aneurysms. Eur J Clin Invest 2013 43 1328 1338. doi: 10.1111/eci.12173
18. Yoshimura K, Aoki H, Recent advances in pharmacotherapy development for abdominal aortic aneurysm. Int J Vasc Med 2012 2012 648167. doi: 10.1155/2012/648167
19. Weintraub NL, Understanding abdominal aortic aneurysm. N Engl J Med 2009 361 1114 1116. doi: 10.1056/NEJMcibr0905244
20. Rateri DL, Howatt DA, Moorleghen JJ, Charnigo R, Cassis LA, Daugherty A, Prolonged infusion of angiotensin II in apoE(-/-) mice promotes macrophage recruitment with continued expansion of abdominal aortic aneurysm. Am J Pathol 2011 179 1542 1548. doi: 10.1016/j.ajpath.2011.05.049
21. Daugherty A, Cassis LA, Mouse models of abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 2004 24 429 434. doi: 10.1161/01.ATV.0000118013.72016.ea
22. Daugherty A, Manning MW, Cassis LA, Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J Clin Invest 2000 105 1605 1612. doi: 10.1172/JCI7818
23. Inoue N, Muramatsu M, Jin D, Takai S, Hayashi T, Katayama H, Kitaura Y, Tamai H, Miyazaki M, Involvement of vascular angiotensin II-forming enzymes in the progression of aortic abdominal aneurysms in angiotensin II-infused ApoE-deficient mice. J Atheroscler Thromb 2009 16 164 171
24. Liao S, Miralles M, Kelley BJ, Curci JA, Borhani M, Thompson RW, Suppression of experimental abdominal aortic aneurysms in the rat by treatment with angiotensin-converting enzyme inhibitors. J Vasc Surg 2001 33 1057 1064. doi: 10.1067/mva.2001.112810
25. Fujiwara Y, Shiraya S, Miyake T, Yamakawa S, Aoki M, Makino H, Nishimura M, Morishita R, Inhibition of experimental abdominal aortic aneurysm in a rat model by the angiotensin receptor blocker valsartan. Int J Mol Med 2008 22 703 708
26. Daugherty A, Manning MW, Cassis LA, Antagonism of AT2 receptors augments angiotensin II-induced abdominal aortic aneurysms and atherosclerosis. Br J Pharmacol 2001 134 865 870. doi: 10.1038/sj.bjp.0704331
27. Gaist D, Sørensen HT, Hallas J, The Danish prescription registries. Dan Med Bull 1997 44 445 448
28. Wilmink TB, Quick CR, Day NE, The association between cigarette smoking and abdominal aortic aneurysms. J Vasc Surg 1999 30 1099 1105
29. Singh K, Bønaa KH, Jacobsen BK, Bjørk L, Solberg S, Prevalence of and risk factors for abdominal aortic aneurysms in a population-based study: the Tromsø Study. Am J Epidemiol 2001 154 236 244